Yi An
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Circular RNAs in diseases 7
- Angiogenesis and VEGF in Cancer 3
-
- Cardiac Fibrosis and Remodeling 3
- Acute Myocardial Infarction Research 3
- Co-authors
- WU Yu-ling (2 shared papers)Jianbing Zhu (3 shared papers)Junbo Ge (3 shared papers)Hongtao Shi (3 shared papers)Leilei Ma (3 shared papers)Jian Wu (2 shared papers)Jian Li (2 shared papers)Nan Lin (1 shared paper)
- Journals
- Scientific Reports (2 papers)International Journal of Cardiology (1 paper)Environmental Toxicology (1 paper)European Journal of Pharmacology (1 paper)Marine Drugs (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yi An
35 papers receiving 796 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 159
- Molecular Medicine 43
- Cardiology and Cardiovascular Medicine 173
- Complementary and alternative medicine 59
- Biomaterials 69
Countries citing papers authored by Yi An
This map shows the geographic impact of Yi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi An more than expected).
Fields of papers citing papers by Yi An
This network shows the impact of papers produced by Yi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi An. The network helps show where Yi An may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 96 | |
| 2 | 2016 | 94 | |
| 3 | 2021 | 56 | |
| 4 | 2021 | 55 | |
| 5 | 2020 | 48 | |
| 6 | 2017 | 40 | |
| 7 | 2012 | 39 | |
| 8 | 2020 | 38 | |
| 9 | 2019 | 36 | |
| 10 | 2019 | 35 | |
| 11 | 2018 | 32 | |
| 12 | 2020 | 31 | |
| 13 | 2020 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2017 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2017 | 11 |
About Yi An
Yi An is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Epidemiology and Cell Biology, having authored 36 papers that have together received 801 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Cancer-related molecular mechanisms research (4 papers), Traditional Chinese Medicine Analysis (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Acute Myocardial Infarction Research (3 papers). The work is most often cited by research in Cancer Research (159 citations), Molecular Medicine (43 citations), Cardiology and Cardiovascular Medicine (173 citations), Complementary and alternative medicine (59 citations) and Biomaterials (69 citations). Yi An has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include WU Yu-ling, Jianbing Zhu, Junbo Ge, Hongtao Shi, Leilei Ma, Jian Wu, Jian Li, Nan Lin, Junjie Guo and Yunzeng Zou. Their work appears in journals such as Scientific Reports, International Journal of Cardiology, Environmental Toxicology, European Journal of Pharmacology and Marine Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.